NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 9 (5) , 367-378
- https://doi.org/10.1016/j.ccr.2006.03.031
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Mechanisms of Prostate Tumorigenesis: Roles for Transcription Factors Nkx3.1 and Egr1Annals of the New York Academy of Sciences, 2005
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- Targeted therapies for prostate cancerEmerging Therapeutic Targets, 2005
- Deletion, Methylation, and Expression of the NKX3.1 Suppressor Gene in Primary Human Prostate CancerCancer Research, 2005
- ANALYSIS OF ANDROGEN REGULATED HOMEOBOX GENE NKX3.1 DURING PROSTATE CARCINOGENESISJournal of Urology, 2004
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Pten Dose Dictates Cancer Progression in the ProstatePLoS Biology, 2003
- Activation of Phosphatidylinositol 3-Kinase/Akt Pathway by Androgen through Interaction of p85α, Androgen Receptor, and SrcJournal of Biological Chemistry, 2003
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- The Hallmarks of CancerCell, 2000